192 related articles for article (PubMed ID: 31997090)
1. Automated GMP compliant production of [
Tshibangu T; Cawthorne C; Serdons K; Pauwels E; Gsell W; Bormans G; Deroose CM; Cleeren F
EJNMMI Radiopharm Chem; 2020 Jan; 5(1):4. PubMed ID: 31997090
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of [
Ahenkorah S; Cawthorne C; Murce E; Deroose CM; Cardinaels T; Seimbille Y; Bormans G; Ooms M; Cleeren F
Nucl Med Biol; 2023; 118-119():108338. PubMed ID: 37018875
[TBL] [Abstract][Full Text] [Related]
3. 3p-C-NETA: A versatile and effective chelator for development of Al
Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
[No Abstract] [Full Text] [Related]
4. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [
Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145
[TBL] [Abstract][Full Text] [Related]
5. [
Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3033-3046. PubMed ID: 32617641
[TBL] [Abstract][Full Text] [Related]
6. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Evaluation of [
Dam JH; Langkjær N; Baun C; Olsen BB; Nielsen AY; Thisgaard H
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296411
[TBL] [Abstract][Full Text] [Related]
8.
Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Boeckxstaens L; Dekervel J; Vandamme T; Lybaert W; den Broeck BV; Laenen A; Clement PM; Geboes K; Cutsem EV; Stroobants S; Verslype C; Bormans G; Deroose CM
J Nucl Med; 2023 Apr; 64(4):632-638. PubMed ID: 36265911
[No Abstract] [Full Text] [Related]
9. FAPI-04 PET/CT Using [
Jiang X; Wang X; Shen T; Yao Y; Chen M; Li Z; Li X; Shen J; Kou Y; Chen S; Zhou X; Luo Z; Cheng Z
Front Oncol; 2021; 11():649148. PubMed ID: 33816303
[No Abstract] [Full Text] [Related]
10. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of [
Boeckxstaens L; Pauwels E; Vandecaveye V; Deckers W; Cleeren F; Dekervel J; Vandamme T; Serdons K; Koole M; Bormans G; Laenen A; Clement PM; Geboes K; Van Cutsem E; Nackaerts K; Stroobants S; Verslype C; Van Laere K; Deroose CM
EJNMMI Res; 2023 Jun; 13(1):53. PubMed ID: 37261615
[TBL] [Abstract][Full Text] [Related]
12. A novel facile method of labeling octreotide with (18)F-fluorine.
Laverman P; McBride WJ; Sharkey RM; Eek A; Joosten L; Oyen WJ; Goldenberg DM; Boerman OC
J Nucl Med; 2010 Mar; 51(3):454-61. PubMed ID: 20150268
[TBL] [Abstract][Full Text] [Related]
13. Second generation Al
Spahn MA; Luyten K; Van Loy T; Sathekge M; Deroose CM; Koole M; Schols D; Vanduffel W; De Vos K; Annaert P; Bormans G; Cleeren F
Nucl Med Biol; 2024; 132-133():108906. PubMed ID: 38518400
[TBL] [Abstract][Full Text] [Related]
14. Microscale radiosynthesis, preclinical imaging and dosimetry study of [
Lisova K; Sergeev M; Evans-Axelsson S; Stuparu AD; Beykan S; Collins J; Jones J; Lassmann M; Herrmann K; Perrin D; Lee JT; Slavik R; van Dam RM
Nucl Med Biol; 2018 Jun; 61():36-44. PubMed ID: 29747035
[TBL] [Abstract][Full Text] [Related]
15. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of using [
Leupe H; Pauwels E; Vandamme T; Van den Broeck B; Lybaert W; Dekervel J; Van Herpe F; Jaekers J; Cleeren F; Hofland J; Brouwers A; Koole M; Bormans G; Van Cutsem E; Geboes K; Laenen A; Verslype C; Stroobants S; Deroose CM
J Neuroendocrinol; 2024 Jun; ():e13420. PubMed ID: 38837825
[TBL] [Abstract][Full Text] [Related]
17. Pre-Clinical Study of the [
Han J; Chen Y; Zhao Y; Zhao X; Zhang J; Wang J; Zhang Z
Front Med (Lausanne); 2022; 9():803005. PubMed ID: 35252244
[TBL] [Abstract][Full Text] [Related]
18.
Gao F; Zhang Y; Chen M; Song Z; Dong R; Qiu S; Shen C; Huang X; Geng H; Cheng W; Hu J
Eur J Pharm Sci; 2024 Feb; 193():106671. PubMed ID: 38104907
[TBL] [Abstract][Full Text] [Related]
19.
Leupe H; Ahenkorah S; Dekervel J; Unterrainer M; Van Cutsem E; Verslype C; Cleeren F; Deroose CM
J Nucl Med; 2023 Jun; 64(6):835-841. PubMed ID: 37169533
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A
PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
